tipifarnib has been researched along with chaetomellic acid a in 1 studies
| Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (chaetomellic acid a) | Trials (chaetomellic acid a) | Recent Studies (post-2010) (chaetomellic acid a) |
|---|---|---|---|---|---|
| 309 | 92 | 94 | 21 | 0 | 7 |
| Protein | Taxonomy | tipifarnib (IC50) | chaetomellic acid a (IC50) |
|---|---|---|---|
| Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | 0.13 | |
| Protein farnesyltransferase subunit beta | Homo sapiens (human) | 0.13 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dubois, J; Farce, A; Ghinet, A; Homerin, G; Nica, AS | 1 |
1 other study(ies) available for tipifarnib and chaetomellic acid a
| Article | Year |
|---|---|
Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitors.
Topics: Antineoplastic Agents; Binding Sites; Catalytic Domain; Cell Line, Tumor; Cell Survival; Chalcones; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Molecular Docking Simulation; Sonication; Structure-Activity Relationship | 2020 |